Skip to main content
. 2022 Dec 22;12:1025594. doi: 10.3389/fonc.2022.1025594

Figure 3.

Figure 3

MiR-194 was identified to be an optimal prognostic biomarker miRNA for GIC. (A) The expression pattern of miR-194 in pan-cancer showed that miR-194 was highly expressed in GIC. (B-D) Low expression of miR-194 was associated with shorter time of overall survival (OVS), disease-specific survival (DSS) and progress-free interval (PFI) in patients with liver cancer (LIHC). (E-G) Low expression of miR-194 was associated with shorter time of OVS, DSS and PFI survival in patients with colorectal cancer (COADREAD). (H-J) Low expression of miR-194 predicted poor OVS, DSS and PFI survival in patients with stomach cancer (STAD).